אינג'י 10 מג80 מג טבליות

Land: Israël

Taal: Hebreeuws

Bron: Ministry of Health

Werkstoffen:

EZETIMIBE; SIMVASTATIN

Beschikbaar vanaf:

MERCK SHARP & DOHME ISRAEL LTD

ATC-code:

C10AA01

farmaceutische vorm:

טבליה

Samenstelling:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Toedieningsweg:

פומי

Prescription-type:

מרשם נדרש

Geproduceerd door:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Therapeutische categorie:

SIMVASTATIN

Therapeutisch gebied:

SIMVASTATIN

therapeutische indicaties:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Autorisatie datum:

2012-04-30